Grass Roots vs. Grass Tops: Tribulations of California's Kickoff Attempt to Deal with Costs of Multimillion Dollar Stem Cell Therapies

Proposal aimed at assisting patients in California

The 35 directors of the $12 billion California stem cell agency spent more than two hours late last month hashing over a tiny, first step in fulfilling a promise to voters to deal with the enormous problem of the affordability of the therapies that the agency is paying to develop. 

That is about twice as long as any of the meetings of the still new CIRM …